WASHINGTON – The Consumer Healthcare Products Association (CHPA) today announced the appointment of Douglas “Duffy” MacKay as senior vice president, Dietary Supplements. MacKay is a highly-respected industry veteran with over two decades of commercial and non-profit experience in nutrition research, dietary supplement regulation, policy development, and association leadership. He will lead CHPA’s cross-functional dietary supplements team, directing strategy, shaping policy, and collaborating with stakeholders to help protect and grow this important, expanding consumer health category on behalf of the CHPA membership. CHPA represents consumer healthcare companies manufacturing and marketing OTC medicines, dietary supplements, and consumer medical devices.
“Duffy is an accomplished and highly-respected leader of the dietary supplements industry, and we couldn’t be more pleased he will be joining CHPA at this important time for the category and for CHPA,” said Scott Melville, president and CEO, CHPA. “Duffy has spent his career advocating for consumers, the industry and the important and growing role that science-backed dietary supplements play in self-care. As such, there is no better person to lead CHPA’s efforts in the dietary supplements category, a key component of the association’s self-care mission, which is rooted in innovation and strong science, ethical leadership, responsible marketing, and more choices for America’s healthcare consumers.”
“I have always admired CHPA’s recognition that safety, product integrity, and industry transparency are key tenants to building trust in consumer healthcare products,” said MacKay. “These tenants align with my personal values, and I am honored for this opportunity to advance CHPA’s dietary supplements agenda. I look forward to being part of CHPA’s proven track record of advancing self-care broadly while accelerating dietary supplement priorities with surgical precision.”
MacKay, a Doctor of Naturopathic Medicine (ND), was most recently the Senior Vice President, Scientific and Regulatory Affairs at CV Sciences, a leading CBD life sciences company. Previously, he served for a decade with the Council for Responsible Nutrition (CRN), leading the organization’s Scientific & Regulatory Affairs function. MacKay also held various positions with supplement manufacturing and research organizations, as well as a private medical practice. He holds a number of health-related professional licenses and affiliations and has authored or co-authored over 30 peer-reviewed articles in professional journals.
MacKay will begin work at CHPA on October 18, 2021 and report directly to CHPA president and CEO, Scott Melville.